Medacta announced the first hip replacement procedures in the U.S. and Europe employing Quadra-P Collared and Quadra-P Cemented femoral stems, following recent FDA 510(k) clearance and approval under the CE Mark.
The two stem options complete Medacta’s Quadra-P system that launched in 2019. Quadra-P is part of the company’s line of P-Stems, along with AMIStem-P and SMS. The tapered rectangular stems all feature proximal coating and progressive neck lengths, with a range of stem lengths and canal filling dimensions to optimally match a patient’s bone morphology.
Quadra-P is enhanced with MectaGrip proximal coating for initial stability, and progressive head center growth that more closely reflects the patient’s natural anatomy.
“Stem selection is a critical component to positive patient outcomes, and the P-Stem Family affords our surgeons the ability to select a distally reduced, collarless, collared or cemented stem that best matches their patient’s femoral bone morphology and bone quality,” said Francesco Siccardi, CEO.
Medacta announced the first hip replacement procedures in the U.S. and Europe employing Quadra-P Collared and Quadra-P Cemented femoral stems, following recent FDA 510(k) clearance and approval under the CE Mark.
The two stem options complete Medacta's Quadra-P system that launched in 2019. Quadra-P is part of the company's line of P-Stems,...
Medacta announced the first hip replacement procedures in the U.S. and Europe employing Quadra-P Collared and Quadra-P Cemented femoral stems, following recent FDA 510(k) clearance and approval under the CE Mark.
The two stem options complete Medacta’s Quadra-P system that launched in 2019. Quadra-P is part of the company’s line of P-Stems, along with AMIStem-P and SMS. The tapered rectangular stems all feature proximal coating and progressive neck lengths, with a range of stem lengths and canal filling dimensions to optimally match a patient’s bone morphology.
Quadra-P is enhanced with MectaGrip proximal coating for initial stability, and progressive head center growth that more closely reflects the patient’s natural anatomy.
“Stem selection is a critical component to positive patient outcomes, and the P-Stem Family affords our surgeons the ability to select a distally reduced, collarless, collared or cemented stem that best matches their patient’s femoral bone morphology and bone quality,” said Francesco Siccardi, CEO.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
